Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies

NCT01463982 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Advanced Cancer

Interventions

DRUG: Oratecan and Capecitabine

Sponsor

Hanmi Pharmaceutical Company Limited